Vercirnon

Vercirnon Uses, Dosage, Side Effects, Food Interaction and all others data.

Vercirnon is a novel, orally active anti-inflammatory agent that targets a chemokine receptor protein implicated in both Crohn's disease and ulcerative colitis, the two principal forms of IBD. It is under investigation in clinical trial NCT01611805 (Japanese Phase I of GSK1605786).

Trade Name Vercirnon
Generic Vercirnon
Vercirnon Other Names Vercirnon
Type
Formula C22H21ClN2O4S
Weight Average: 444.93
Monoisotopic: 444.091056
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Vercirnon
Vercirnon

How Vercirnon works

Vercirnon, a small molecule, orally-available drug, is intended to control the inappropriate immune system response underlying IBD by blocking the activity of the CCR9 chemokine receptor. In adults, CCR9 is a highly specific receptor expressed by T cells that migrate selectively to the digestive tract. The trafficking of T cells to the small and large intestine causes persistent inflammation that may result in Crohn's disease or ulcerative colitis - the two principal forms of IBD.

Innovators Monograph

You find simplified version here Vercirnon

*** Taking medicines without doctor's advice can cause long-term problems.
Share